The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports research to understand, treat, and prevent infectious and allergic diseases.

The National Institute of Allergy and Infectious Diseases (NIAID, / ˈnaɪ.æd /) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS).

2021年6月21日 · An overview of the NIAID organization including resources about extramural and intramural divisions.

2024年12月17日 · On October 1, 2024, NIAID set interim paylines for fiscal year 2025 for all relevant grant types. This includes a note to explain a switch for fellowships from overall impact score to percentiles as well as disaggregating career development award paylines.

The National Institute of Allergy and Infectious Diseases (NIAID) provides health information on allergic, infectious, and immunologic diseases. Diseases include food allergy, sinusitis, and genital herpes.

The Collaborative Influenza Vaccine Innovation Centers (CIVICs) program was created by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to develop more durable, broadly protective, and longer-lasting influenza vaccines.

2023年4月21日 · The NIAID Division of Intramural Research (DIR) conducts basic and clinical research in a wide range of disciplines related to immunology, allergy, and infectious diseases.

2023年12月19日 · NIAID research strives to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten millions of human lives.

NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States ...

2023年8月2日 · As NIAID director, Dr. Marrazzo will oversee NIAID’s budget of $6.3 billion, which supports research to advance the understanding, diagnosis and treatment of infectious, immunologic and allergic diseases.